Meeting to be held in New York on June 4 hosted by Piper Sandler.
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ATYR:
- Buy Rating for aTyr Pharma: Confidence in EFZO-FIT Phase 3 Trial Success
- aTyr Pharma presents three posters on efzofitimod at ATS 2025 Conference
- aTyr Pharma’s Innovative Fibrosis Treatment and Promising Pipeline Garner Buy Rating
- aTyr Pharma advances ATYR0101 to IND candidate stage for pulmonary fibrosis
- Positive Outlook for aTyr Pharma: Buy Rating Reaffirmed Amid Promising EFZO-FIT Trial Prospects